Transient expression of miR-373 and siRNA-based knockdown of Rab22a showed essentially similar effects in ovarian cancer cells, further confirming that direct targeting of Rab22a by miR-337 plays an important inhibitory role in migration and invasion of ovarian cancer cells. Here, RAB22A is linked to ovarian cancer.